Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits
Pfizer (NYSE:PFE) Stock Price Down 0.6% - Should You Sell?
Pzena Investment Management LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
Pfizer Inc. (NYSE:PFE) Shares Sold by Moors & Cabot Inc.
News Highlights: Top Company News of the Day - Wednesday at 9 AM ET | Morningstar
First Horizon Advisors Inc. Purchases 95,749 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies | Morningstar
Advisors Asset Management Inc. Acquires 28,704 Shares of Pfizer Inc. (NYSE:PFE)
News Highlights: Top Company News of the Day - Wednesday at 7 AM ET | Morningstar
Commerce Bank Has $60.56 Million Stake in Pfizer Inc. (NYSE:PFE)
Pfizer Names Oncology Head Boshoff as Chief Science Officer
Pfizer Gets European Approval of Hympavzi Hemophilia Drug | Morningstar
Pfizer names Chris Boshoff as new R&D chief starting 2025 By Investing.com
Pfizer Inc. (NYSE:PFE) Shares Bought by Pathstone Holdings LLC
Pfizer Inc. (NYSE:PFE) Stake Raised by Thrivent Financial for Lutherans
Pfizer's HYMPAVZI Approved In EU For Treatment Of Severe Hemophilia A Or B Without Inhibitors
StockNews.com Downgrades Pfizer (NYSE:PFE) to Buy
Pfizer names insider Chris Boshoff as R&D chief By Reuters
Pfizer Appoints Chris Boshoff as Chief Scientific Officer and President of R&D By Investing.com
Pfizer Announces EU Approval of HYMPAVZI for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors By Investing.com
SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - November 20, 2024 - Zacks.com
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan - November 20, 2024 - Zacks.com
5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential - November 20, 2024 - Zacks.com
Pfizer names oncology chief Chris Boshoff as new chief scientific officer | Morningstar
Healthcare Players React To Dr. Oz Joining RFK Jr In Trump Lineup 11/21/2024
Pfizer (NYSE:PFE) Trading Up 0.7% - Here's What Happened
Pfizer Inc. (NYSE:PFE) Shares Acquired by Meeder Advisory Services Inc.
High-Flying Genetics Testing Firm GeneDx Hires Ex-Zoetis GC as Legal Chief
Pfizer Inc. (NYSE:PFE) Holdings Lowered by PNC Financial Services Group Inc.
Pfizer Inc. (NYSE:PFE) Holdings Lowered by Banque Cantonale Vaudoise
Verity & Verity LLC Purchases 108,863 Shares of Pfizer Inc. (NYSE:PFE)
OneAscent Financial Services LLC Invests $739,000 in Pfizer Inc. (NYSE:PFE)
Belmont Capital LLC Has $270,000 Stake in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Holdings Decreased by AMG National Trust Bank
These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth - November 19, 2024 - Zacks.com
The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm - November 19, 2024 - Zacks.com
Antifungal Drugs Market Growth Driven by Rising Fungal Infections Worldwide – Express Press Release Distribution
Global Narcolepsy Treatment Market Set to Reach USD 6.67 Billion by 2028 at a 5.7% of CAGR, Driven by Advancements in Care and Growing Awareness – Express Press Release Distribution
Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’
Pfizer (NYSE:PFE) Stock Price Up 0.6% - Here's What Happened
Jim Cramer Talked About These 11 Stocks Recently
Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now?
TrinityPoint Wealth LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)
Vaughan Nelson Investment Management L.P. Has $2.57 Million Position in Pfizer Inc. (NYSE:PFE)
Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short Term - November 18, 2024 - Zacks.com
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria - November 18, 2024 - Zacks.com
Pfizer Inc. (NYSE:PFE) Given Average Recommendation of "Moderate Buy" by Brokerages
Latest news
MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K
Nasdaq futures decline, Nvidia shares dip following the earnings report
Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024